An involvement of St 155 [2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, catapres] in cholinergic mechanisms.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D005260:Female; D005263:Femoral Artery / Q000187:drug effects; D006145:Guanethidine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects*; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D009638:Norepinephrine; D013565:Sympatholytics / Q000494:pharmacology*; D014628:Vagotomy; D014630:Vagus Nerve / Q000187:drug effects*
D004983:Ethanolamines; D007093:Imidazoles; D013565:Sympatholytics; D001285:Atropine; D009638:Norepinephrine; D004837:Epinephrine; D006145:Guanethidine